QureBio has raised about 200 million yuan ($31 million) in its Series B round of financing, while Galaxy Future Technology has secured $10 million in its angel and angel+ rounds.
QureBio nabs nearly $31m in Series B
Biopharmaceutical firm QureBio has secured approximately 200 million yuan ($31 million) in its Series B round led by the affiliate industry fund of Bank of Communications’ BOCOM International.
